Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | OGG1 | O15527 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25646088 | 0.88 | ALOX5 (0.47) | WDR5TSHRMAOBRXRARXRB | |
| SCHEMBL240715 | 0.82 | WDR5 (0.44) | WDR5TSHROGG1LMNAMAPK1 | |
| SCHEMBL25646089 | 0.79 | CYP1A2 (0.43) | HTTSMN1; SMN2RXRARXRBCYP1A2 | |
| SCHEMBL25646094 | 0.79 | ALOX5 (0.50) | MAOB | |
| SCHEMBL4621505 | 0.77 | NPC1 (0.51) | WDR5TSHRLMNASMN1; SMN2KMT2A | |
| SCHEMBL14664933 | 0.77 | TSHR (0.42) | WDR5TSHRLMNAMAPK1HTT | |
| SCHEMBL11955396 | 0.76 | CYP3A4 (0.48) | TSHRLMNACYP2C9DRD2DRD4 | |
| SCHEMBL16302122 | 0.75 | — | — | |
| SCHEMBL31253853 | 0.75 | — | — | |
| SCHEMBL16547240 | 0.74 | SLC6A2 (0.39) | SLC6A4CYP2D6CYP1A2CYP2C19SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101333226-A | Chiral dual ring [4.4.0] diborate and method for preparing same | UNIV WUHAN (CN) | 2008-12-31 | — | — | CN | claimed |
| US-12024536-B2 | C-terminal HSP90 inhibitors | UNIVERSITY OF KANSAS (US) | 2024-07-02 | — | — | US | disclosed |
| US-11985894-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-05-14 | — | — | US | disclosed |
| US-20240023432-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | LT MATERIALS CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240023429-A1 | MONOAMINE COMPOUND AND LIGHT EMITTING ELEMENT INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240018103-A1 | 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST | RAQUALIA PHARMA INC. (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11795155-B2 | Compound having naphthobenzofuranyl structure, material for organic electroluminescence device, organic electroluminescence device, and electronic instrument | IDEMITSU KOSAN CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-11785847-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20230312501-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230276707-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-8575357-B2 | Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof | AICURIS GMBH & CO. KG (DE) | 2013-11-05 | — | — | US | disclosed |
| US-8546438-B2 | Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2013-10-01 | — | — | US | disclosed |
| US-20130045999-A1 | SUBSTITUTED (THIAZOLYL-CARBONYL)IMIDAZOLIDINONES AND USE THEREOF | AICURIS GMBH & CO. KG (DE) | 2013-02-21 | — | — | US | disclosed |
| US-8361959-B2 | Spiro-imidazolone derivatives as glucagon receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20130012434-A1 | NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE | MERCK SHARP & DOHME CORP. | 2013-01-10 | — | — | US | disclosed |
| US-8324268-B2 | Substituted furancarboxamides, and use thereof | AICURIS GMBH & CO. KG (DE) | 2012-12-04 | — | — | US | disclosed |
| US-20120022123-A1 | SUBSTITUTED (THIOPHENYL-CARBONYL)IMIDAZOLIDINONES, AND USE THEREOF | AICURIS GMBH & CO. KG (DE) | 2012-01-26 | — | — | US | disclosed |
| US-20120022059-A1 | SUBSTITUTED FURANCARBOXAMIDES, AND USE THEREOF | AICURIS GMBH & CO. KG (DE) | 2012-01-26 | — | — | US | disclosed |
| US-20100331300-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-12-30 | — | — | US | disclosed |
| CN-101333226-A | Chiral dual ring [4.4.0] diborate and method for preparing same | UNIV WUHAN (CN) | 2008-12-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11785847-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, ESR1, OR51E2 | WDR5 2856/4885TSHR 4374/4885OGG1 106/4885 |
| US-20240018103-A1 | 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST | CRHR2, CRHR1, CRH | WDR5 934/4885TSHR 295/4885OGG1 4042/4885 |
| US-11795155-B2 | Compound having naphthobenzofuranyl structure, material for organic electroluminescence device, organic electroluminescence device, and electronic instrument | L1CAM, LEF1, ARL1 | WDR5 3656/4885TSHR 2275/4885OGG1 1157/4885 |
| US-20130045999-A1 | SUBSTITUTED (THIAZOLYL-CARBONYL)IMIDAZOLIDINONES AND USE THEREOF | TPMT, AADAC, PAICS | WDR5 1878/4885TSHR 3092/4885OGG1 2950/4885 |
| US-20230276707-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | WDR5 2856/4885TSHR 4374/4885OGG1 106/4885 |
| US-20230312501-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, RER1, L1CAM | WDR5 3184/4885TSHR 2174/4885OGG1 3049/4885 |
| US-20240023432-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | CYP1B1, NOTUM, CYP4F11 | WDR5 2371/4885TSHR 4308/4885OGG1 447/4885 |
| US-20120022059-A1 | SUBSTITUTED FURANCARBOXAMIDES, AND USE THEREOF | AADAC, DDC, TPMT | WDR5 2505/4885TSHR 4662/4885OGG1 2193/4885 |
| US-20130012434-A1 | NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE | GLP1R, GCGR, GIPR | WDR5 2871/4885TSHR 44/4885OGG1 4055/4885 |
| US-12024536-B2 | C-terminal HSP90 inhibitors | HSP90AB2P, HSP90AB1, HSP90B1 | WDR5 1900/4885TSHR 3983/4885OGG1 1870/4885 |
| US-11985894-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, ESR1, OR51E2 | WDR5 3054/4885TSHR 4284/4885OGG1 129/4885 |
| US-20240023429-A1 | MONOAMINE COMPOUND AND LIGHT EMITTING ELEMENT INCLUDING THE SAME | MAOA, TPH1, MAOB | WDR5 2399/4885TSHR 1007/4885OGG1 1817/4885 |
| US-20100331300-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | PNLIP, LPL, LIPA | WDR5 1888/4885TSHR 2931/4885OGG1 2595/4885 |
| US-20120022123-A1 | SUBSTITUTED (THIOPHENYL-CARBONYL)IMIDAZOLIDINONES, AND USE THEREOF | TPMT, MAVS, EIF2AK2 | WDR5 2594/4885TSHR 2863/4885OGG1 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.